The official blog of the Lung Institute.

Emphysema Treatment: What’s New?

24 Aug 2016
| Under Emphysema, Lung Disease, Medical | Posted by | 8 Comments
Emphysema Treatment: What’s New?

Emphysema and chronic bronchitis fall under the category of chronic obstructive pulmonary disease (COPD). These chronic lung diseases are progressive, meaning they will worsen over time. However, when it comes to emphysema treatment, advancements or new emphysema treatment, options can seem lacking. While there are traditional emphysema treatment options available such as inhalers, medications and supplemental oxygen, there are doctors and researchers searching for better emphysema treatments for their patients every day. With your health in mind, the Lung Institute has done some research to see what’s new in emphysema treatment options.

3. Lung Coils for Emphysema Treatment

It may sound like something out of a science fiction novel, but scientists have seen promising results in a new study on lung coils for emphysema treatment. While the lung coils procedure is not yet approved by the FDA, doctors are hopeful that it will be approved in the near future.

Here’s how the study worked. The researchers assigned 100 study participants with severe emphysema to either a standard treatment group or the lung coils group. The standard treatment group involved medication, rehabilitation and oxygen. The lung coils group only received the lungs coils emphysema treatment, which is when metal coils are placed into the lungs using a minimally invasive scope. The researchers believe that the metal coils could bring elasticity back to the lungs as well as help keep airways open to provide better airflow.

The results showed that patients who received the lung coils reported an improved quality of life and had greater improvement in a walking test than those in the standard group who didn’t receive the lung coils.

2. Neutrophil Extracellular Trap Biomarker Detection for Emphysema Treatment

A study on neutrophil extracellular trap (NET) biomarker detection could help pinpoint emphysema and COPD patients who won’t respond well to standard emphysema treatment. Because this discovery could tell researchers more about how COPD progresses, it may also shed light on ways to improve treatment.

This new discovery demonstrates how neutrophil airway inflammation is associated with COPD. Neutrophils are white blood cells that are important in fighting infections in the body. The scientists found that a type of neutrophil behavior called neutrophil extracellular trap (NET) formation in the lungs of patients with COPD and emphysema appears to reduce the neutrophils’ ability to fight bacteria.

For this study, researchers collected blood and sputum samples from 141 patients at the end of a flare-up. The researchers found that amount of NET formations in the patients’ lungs directly related to the severity of their lung disease as well as their risk of flare-ups that didn’t respond to treatment with corticosteroids, a traditional emphysema treatment.

The researchers concluded that NET formations resulted in more infections, and worsened lung function and quality of life. The good news is that having this new information about NET formations and being able to identify patients with NET formations will help doctors tailor emphysema treatments to their patients’ needs. While researchers continue to study why NET formations occur and ways to prevent or treat them, there is new hope to improve emphysema treatment options for patients.

1. Stem Cell Therapy for Emphysema Treatment

Emphysema Treatment: What’s New?

Because stem cells are the body’s building blocks, they have the unique ability to self-renew and replicate. Autologous adult stem cells are derived from the patient’s body through blood or bone marrow. Unlike traditional emphysema treatment options that only manage symptoms, stem cell therapy instead directly addresses the disease at its source. Because these remarkable cells can promote healing from within, stem cell therapy is an effective option for emphysema treatment.

At the Lung Institute, stem cells are extracted from a patient’s blood or bone marrow. Next, the stem cells are separated from other cells in the sample in an on-site lab and returned to the patient intravenously. Once returned to the patient, the stem cells can work to promote healing within the lungs, potentially improving lung function.

A recent study produced by the clinic indicated that 82 percent of patients saw an increase in quality of life after stem cell treatment, and 60 percent of those who took a pulmonary function test reported an increase in lung function.

With advancements like stem cell therapy, addressing the disease at its source offers people an option that could help them regain their quality of life. If you or a loved one has emphysema, chronic bronchitis, COPD or another form of lung disease and would like to learn more about stem cell treatment options, contact us at (800) 729-3065.


  1. M R

    7 months ago

    Hello Vicki,
    Thank you for your question. The Lung Institute operates five clinic across the United States in Pittsburgh, PA; Nashville, TN; Tampa, FL; Dallas, TX; and Scottsdale, AZ. We do not operate any clinics outside the U.S. Unfortunately, we do not have any recommendations for stem cell therapy clinics in Australia. If you have any questions about the Lung Institute, please give us a call at (855) 313-1149. Thanks again and have a great day.

  2. Vicki

    7 months ago

    I have been reading your article with great interest, as I have recently been diagnosed with Emphysema.
    I just wondered if there is anywhere in Australia that I could contact regarding Stem Cell Therapy?
    I look forward to your response.
    Many thanks

  3. PB

    11 months ago

    Dear Merri,

    Unfortunately, at this time, insurance companies don’t cover treatment. However, we’re hopeful that treatment will be covered by insurance companies in the near future. Keep in mind that it will take some time before the insurance companies see a financial benefit in their favor and then decide to cover it. In the meantime, you can learn more about stem cell treatment options and have your questions answered by one of our patient coordinators. Feel free to contact us at (855) 313-1149 for more information. We look forward to hearing from you soon.

    Best Regards,

    The Lung Institute

  4. merri

    12 months ago

    Do you take any insurance?

  5. PB

    12 months ago

    Dear Roberta,

    Thanks for your question. In order to qualify for treatment, patients need to be smoke-free for a minimum of 30 days. However, we encourage all people who currently smoke to quit smoking for good. We offer patients a free 4-week smoking cessation guide to help them reach their goal of quitting smoking. To download the free 4-week smoking cessation guide, click here. Also, feel free to contact us at (855) 313-1149 to speak one-on-one with a patient coordinator to have your questions about stem cell therapy answered. We hope this is helpful, and we look forward to speaking with you soon.

    Best Regards,

    The Lung Institute

  6. Roberta Zajac

    12 months ago

    Can a stem cell procedure be done on a patient who still smokes

  7. sh

    12 months ago

    Hello, Maureen.

    There is no age restriction for stem cell therapy. Please give us a call at (855) 313-1149 for answers to any other questions you might have.

    The Lung Institute

  8. Maureen Krupa

    12 months ago

    What is the age cut-off for this stem cell therapy? My husband is 72.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.